Division of Medical Device AMED is supporting the implementation verification of a device that enables rapid PCR testing for the novel coronavirus
Advanced Technology Development Program for Medical Devices and Systems, etc. (Basic Technology Development Project)
Rapid R&D is now required to address the novel coronavirus disease (COVID-19) that has spread worldwide since its first outbreak reported in the People’s Republic of China in December 2019.
In view of this urgent public health need, AMED is supporting R&D projects in the areas described below as part of a government-wide initiative.
|Research Period||Principal Investigator||Affiliation||Project Title||Abstract|
|R1||Toru Shionoya||KYORIN Pharmaceutical Co., Ltd.
In vitro Diagnostics Business division
|Implementation verification of Rapid Virus Detection Device||On January 31, the World Health Organization declared a public health emergency of international concern (PHEIC) on the novel coronavirus disease that was first reported in the People’s Republic of China, and the disease is persistently spreading thereafter. Under this situation, in Japan where the number of patients infected with the virus is increasing, development of a PCR virus test device that reduces the time required for virus detection from the present 2–3 hours to about 15 minutes is urgently needed. To enable the use of a rapid virus detection device (GeneSoc) developed by the National Institute of Advanced Industrial Science and Technology (AIST) for the detection of this novel coronavirus, we will introduce this device to institutions where conventional PCR devices have been used. The research group will verify the effectiveness and operability of the new device in clinical practice to accelerate its actual use.|
Last updated 2020.3.24